CareDx Q2 FY26 GAAP net income swings to USD 110.64 million; revenue rises 52% to USD 132 million - CDNA News | RalliesCareDx Q2 FY26 GAAP net income swings to USD 110.64 million; revenue rises 52% to USD 132 million
C
CDNA• Full-year outlook
- CareDx raised full-year revenue guidance to USD 460 million-USD 500 million; adjusted EBITDA outlook increased to USD 66 million-USD 78 million.
Volume and balance sheet
- Testing services volume increased 17% to 58,000.
- Cash at quarter-end totaled USD 374 million with no debt.
Q2 revenue and profitability
- CareDx Q2 2026 revenue climbed 52% year over year to USD 132 million; testing services revenue rose 61% to USD 100 million.
- GAAP net income swung to USD 110.64 million, reflecting a USD 112.67 million gain on the lab products divestiture.
- Adjusted EBITDA rose to USD 24.8 million from USD 5.31 million; adjusted EBITDA margin widened to 16% from 6%.
•
